Randomized Trial: Low-Dose Imipramine for Refractory Functional Dyspepsia
30 Nov, 2018 | 02:57h | UTCLow-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary: Low-Dose Imipramine Alternative Treatment for Refractory Functional Dyspepsia – Clinical Advisor (free)